Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
Part of paid clinical trials in Austin, Texas.
- Sponsor
- Natera, Inc.
- Study ID
- NCT07046585
- Status
- Recruiting
Conditions
- Colo-rectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.
Key Dates
- Start date
- May 30, 2025
- Status verified
- Dec 2025
- Primary completion
- Jul 10, 2027
- Completion
- Sep 30, 2033
Study Design
- Enrollment
- 25,000 participants (estimated)
Arms
- Arm: Participants at average risk for colorectal cancerParticipants 40 years of age or older at time of consent, planning or intending to undergo asymptomatic screening colonoscopy.
Primary Outcome Measure
Primary Outcome [ Time Frame: 24 months ]
Central Contacts
- FIND-CRC Study team650-489-9050
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Natera, Inc | Austin | Texas | 78753 | - |
Find similar trials in Austin, TX
By research site
Related Studies
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPHASE2 · Recruiting · Vyriad, Inc. · Phoenix, Arizona
- Shield Post-Approval Study ProtocolRecruiting · Guardant Health, Inc. · Chandler, Arizona
- A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsPHASE1 · Recruiting · ALX Oncology Inc. · Tampa, Florida
- Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPHASE1/PHASE2 · Recruiting · MBrace Therapeutics · San Francisco, California